The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort

Biological Psychiatry
Magnus LekmanSilvia Paddock

Abstract

In a recent study of several antidepressant drugs in hospitalized, non-Hispanic White patients, Binder et al. reported association of markers located within the FKBP5 gene with treatment response after 2 and 5 weeks. Individuals homozygous for the TT-genotype at one of the markers (rs1360780) reported more depressive episodes and responded better to antidepressant treatment. There was no association between markers in FKBP5 and disease. The present study aimed at studying the associated FKBP5 markers in the ethnically diverse Sequenced Treatment Alternatives to Relieve Depression (STAR*D) sample of non-hospitalized patients treated with citalopram. We used clinical data and DNA samples from 1809 outpatients with non-psychotic major depressive disorder (DSM-IV criteria), who received up to 14 weeks of citalopram. A subset of 1523 patients of White non-Hispanic or Black race was matched with 739 control subjects for a case-control analysis. The markers rs1360780 and rs4713916 were genotyped on the Illumina platform. TaqMan-assay was used for marker rs3800373. In the case-control analysis, marker rs1360780 was significantly associated with disease status in the White non-Hispanic sample after correction for multiple testing. A sig...Continue Reading

References

Jul 1, 1997·Archives of General Psychiatry·R S DumanE J Nestler
Nov 11, 1998·Nature Medicine·A D Lopez, C C Murray
Jun 12, 1999·American Journal of Human Genetics·J K Pritchard, N A Rosenberg
May 29, 2000·American Journal of Human Genetics·J K PritchardP Donnelly
Jun 3, 2000·Genetics·J K PritchardP Donnelly
Mar 29, 2001·Biological Psychiatry·C M Pariante, A H Miller
Nov 27, 2001·Biological Psychiatry·P W LavoriM Trivedi
Apr 10, 2002·JAMA : the Journal of the American Medical Association·B Timothy WalshMadelyn Gould
Jun 5, 2003·The Psychiatric Clinics of North America·Maurizio FavaDavid J Kupfer
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Apr 6, 2004·Controlled Clinical Trials·A John RushUNKNOWN STAR*D Investigators Group
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Abdalla Salem Elhwuegi
May 5, 2004·The British Journal of Psychiatry : the Journal of Mental Science·T B UstünC J L Murray
Jun 5, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·I Hindmarch
Apr 30, 2005·Pharmacogenetics and Genomics·Alessandro SerrettiRoberto Quartesan
Jan 5, 2006·The American Journal of Psychiatry·Madhukar H TrivediUNKNOWN STAR*D Study Team
Jan 10, 2006·CNS Spectrums·Akira Kugaya, Gerard Sanacora
Apr 28, 2006·American Journal of Human Genetics·Francis J McMahonHusseini Manji
Dec 16, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·George I Papakostas, Maurizio Fava
Aug 3, 2007·The American Journal of Psychiatry·Silvia PaddockFrancis J McMahon

❮ Previous
Next ❯

Citations

Jan 5, 2010·European Archives of Psychiatry and Clinical Neuroscience·Astrid Zobel, Wolfgang Maier
Feb 10, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Erick T TatroUNKNOWN HIV Neurobehavioral Research Center
Dec 27, 2011·Current Psychiatry Reports·Robert Keers, Rudolf Uher
Nov 20, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sonja HorstmannElisabeth B Binder
Apr 16, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Pingxing XieJoel Gelernter
Jun 10, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Katja AppelHans J Grabe
Jul 12, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Fleur P VeldersHenning Tiemeier
Sep 20, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Annamaria CattaneoCarmine M Pariante
Jun 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sungho MaengHusseini K Manji
Oct 30, 2013·Disease Markers·Ulrike SchmidtCarsten T Wotjak
Oct 30, 2013·Disease Markers·Christiana LabermaierMarianne B Müller
Nov 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Gonzalo LajeFrancis J McMahon
May 18, 2013·BMC Medicine·Uzoezi OzomaroCharles B Nemeroff
May 2, 2009·Disease Models & Mechanisms·Oz MalkesmanHusseini K Manji
Feb 25, 2011·PloS One·Sebastian H ScharfMarianne B Müller
Apr 25, 2014·PloS One·Lianne HoeijmakersJakob Hartmann
Dec 22, 2010·Journal of Psychiatry & Neuroscience : JPN·Stefano PorcelliAlessandro Serretti
Dec 21, 2010·Journal of Psychiatry & Neuroscience : JPN·Simon N Young
Jul 4, 2008·Pharmacogenomics·Julia KirchheinerJürgen Brockmöller
Jul 4, 2008·Pharmacogenomics·Eugene Lin, Po See Chen
Mar 3, 2012·Pharmacogenomics·Sneha Narasimhan, Falk W Lohoff
Mar 14, 2009·European Journal of Endocrinology·Kristian LøvåsEystein S Husebye
Jul 3, 2013·Psychological Medicine·N AntypaA Serretti
May 7, 2014·Pharmacogenomics·Zuzanna E ZajkowskaPatricia A Zunszain
Aug 16, 2013·BMC Psychiatry·Fayaz SeifuddinPeter P Zandi
Dec 29, 2012·Cellular and Molecular Life Sciences : CMLS·Cristina LanniStefano Govoni
Nov 15, 2015·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Xiaochen LuoCatharina A Hartman
Mar 15, 2011·Expert Opinion on Investigational Drugs·Marcelo Paez-PeredaFlorian Holsboer
Jun 17, 2014·Expert Opinion on Drug Metabolism & Toxicology·Chiara FabbriAlessandro Serretti
Jan 24, 2016·Brain Imaging and Behavior·Aldo Córdova-PalomeraLourdes Fañanás

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.